Skip to main content
Top
Published in: Journal of General Internal Medicine 7/2017

01-07-2017 | Capsule Commentary

Capsule Commentary on Saloner et al., Price Transparency in Primary Care: Can Patients Learn About Costs When Scheduling an Appointment?

Author: Cameron M. Kaplan, PhD

Published in: Journal of General Internal Medicine | Issue 7/2017

Login to get access

Excerpt

One of the promises of the recent push for high-deductible, consumer-driven health plans is that they can reduce health care costs and improve quality, because patients can comparison-shop. However, this promise can be fulfilled only if patients have access to price information and use it to make decisions. Primary care is an important area in which to examine price transparency, because it is easy for patients to plan ahead for and thus to perform cost comparisons. Additionally, primary care is widely used and is often subject to patients’ deductibles. At the same time, new requirements for insurers to cover certain preventive services without a co-pay adds to the confusion about how much typical primary care visits will cost. …
Literature
1.
go back to reference Saloner B, Cope LC, Hempstead K, Rhodes KV, Polsky D, Kenney GM. Price transparency in primary care: can patients learn about costs when scheduling an appointment? J Gen Intern Med. 2017. doi:10.1007/s11606-017-4003-4. Saloner B, Cope LC, Hempstead K, Rhodes KV, Polsky D, Kenney GM. Price transparency in primary care: can patients learn about costs when scheduling an appointment? J Gen Intern Med. 2017. doi:10.​1007/​s11606-017-4003-4.
2.
go back to reference Sinaiko AD, Rosenthal MB. Examining a health care price transparency tool: who uses it, and how they shop for care. Health Aff. 2016;35(4):662–670.CrossRef Sinaiko AD, Rosenthal MB. Examining a health care price transparency tool: who uses it, and how they shop for care. Health Aff. 2016;35(4):662–670.CrossRef
3.
go back to reference Desai S, Hatfield LA, Hicks AL, Chernew ME, Mehrotra A. Association between availability of a price transparency tool and outpatient spending. JAMA. 2016;315(17):1874–1881.CrossRefPubMed Desai S, Hatfield LA, Hicks AL, Chernew ME, Mehrotra A. Association between availability of a price transparency tool and outpatient spending. JAMA. 2016;315(17):1874–1881.CrossRefPubMed
Metadata
Title
Capsule Commentary on Saloner et al., Price Transparency in Primary Care: Can Patients Learn About Costs When Scheduling an Appointment?
Author
Cameron M. Kaplan, PhD
Publication date
01-07-2017
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 7/2017
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-017-4055-5

Other articles of this Issue 7/2017

Journal of General Internal Medicine 7/2017 Go to the issue

Clinical Practice: Clinical Images

Skeletal Tuberculosis

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.